grant

Molecular Mechanisms of the Dysregulated Immune Response to Ebola Virus

Organization UNIVERSITY OF TEXAS MED BR GALVESTONLocation GALVESTON, UNITED STATESPosted 15 Apr 2021Deadline 31 Mar 2027
NIHUS FederalResearch GrantFY20252019 novel corona virus2019 novel coronavirus2019-nCoVAcuteAddressAfricaAlternate SplicingAlternative RNA SplicingAlternative SplicingApoptosisApoptosis PathwayBasal Transcription FactorBasal transcription factor genesBehaviorBelgian CongoBioinformaticsBody TissuesCOVID crisisCOVID epidemicCOVID pandemicCOVID-19COVID-19 crisisCOVID-19 epidemicCOVID-19 eraCOVID-19 global health crisisCOVID-19 global pandemicCOVID-19 health crisisCOVID-19 pandemicCOVID-19 periodCOVID-19 public health crisisCOVID-19 virusCOVID-19 yearsCOVID19 virusCV-19Cell BodyCellsCessation of lifeCoV-2CoV2CollaborationsCommunicationComplexCoronavirus Infectious Disease 2019DataDeathDemocratic Republic of the CongoDendritic CellsDevelopmentDisease OutbreaksEBOVEBOV GPEbola Hemorrhagic FeverEbola Virus DiseaseEbola diseaseEbola virusEbola virus GP gene productEbola virus envelope glycoproteinEbola-like VirusesEpigeneticEpigenetic ChangeEpigenetic MechanismEpigenetic ProcessEvaluationEventExperimental DesignsFrankfurt-Marburg Syndrome VirusGP Ebola virusGene ExpressionGene TranscriptionGeneral Transcription Factor GeneGeneral Transcription FactorsGenetic TranscriptionHDACHDAC ProteinsHistone DeacetylaseHomolog of Drosophila TOLLHumanIFNImmuneImmune ToleranceImmune responseImmunesImmunoglobulin Enhancer-Binding ProteinImmunologic ToleranceIndividualInfectionInflammationInterferonsInvestigationKnowledgeLassa fever virusLassa virusLeadLymphocytopeniaLymphopeniaMarburgMarburg virusMarburg-like VirusesMarburgvirusMass Photometry/Spectrum AnalysisMass SpectrometryMass SpectroscopyMass SpectrumMass Spectrum AnalysesMass Spectrum AnalysisMassive Parallel SequencingMassively Parallel DNA SequencingMassively Parallel SequencingModelingModern ManModificationMolecularNF-kBNF-kappa BNF-kappaBNFKBNon-Polyadenylated RNANuclear Factor kappa BNuclear Transcription Factor NF-kBOrthoebolavirusOrthomarburgvirusOutbreaksOutcomeP01 MechanismP01 ProgramPaintPathogenesisPathogenicityPathologicPb elementPhosphorylationPopulationPost-Translational Modification Protein/Amino Acid BiochemistryPost-Translational ModificationsPost-Translational Protein ModificationPost-Translational Protein ProcessingPosttranslational ModificationsPosttranslational Protein ProcessingProgram Project GrantProgram Research Project GrantsProgrammed Cell DeathProtein ModificationProtein PhosphorylationPublic HealthR-Series Research ProjectsR01 MechanismR01 ProgramRNARNA ExpressionRNA Gene ProductsResearchResearch GrantsResearch Program ProjectsResearch Project GrantsResearch ProjectsRibonucleic AcidRoleRunningSARS corona virus 2SARS-CO-V2SARS-COVID-2SARS-CoV-2SARS-CoV-2 epidemicSARS-CoV-2 global health crisisSARS-CoV-2 global pandemicSARS-CoV-2 pandemicSARS-CoV2SARS-associated corona virus 2SARS-associated coronavirus 2SARS-coronavirus-2SARS-coronavirus-2 epidemicSARS-coronavirus-2 pandemicSARS-related corona virus 2SARS-related coronavirus 2SARSCoV2SamplingSevere Acute Respiratory Coronavirus 2Severe Acute Respiratory Distress Syndrome CoV 2Severe Acute Respiratory Distress Syndrome Corona Virus 2Severe Acute Respiratory Distress Syndrome Coronavirus 2Severe Acute Respiratory Syndrome CoV 2Severe Acute Respiratory Syndrome CoV 2 epidemicSevere Acute Respiratory Syndrome CoV 2 pandemicSevere Acute Respiratory Syndrome-associated coronavirus 2Severe Acute Respiratory Syndrome-related coronavirus 2Severe acute respiratory syndrome associated corona virus 2Severe acute respiratory syndrome coronavirus 2Severe acute respiratory syndrome coronavirus 2 epidemicSevere acute respiratory syndrome coronavirus 2 pandemicSevere acute respiratory syndrome related corona virus 2Strategic PlanningT-CellsT-LymphocyteTLR4TLR4 geneTestingTissuesToll HomologueTranscriptionTranscription Factor NF-kBTranscription Factor Proto-OncogeneTranscription factor genesTranslation AlterationUbiquitilationUbiquitinationUbiquitinoylationValidationVeiled CellsViral DiseasesViral Hemorrhagic FeversVirusVirus DiseasesWorkWuhan coronavirusZaireantagonismantagonistcell typecoronavirus disease 2019coronavirus disease 2019 crisiscoronavirus disease 2019 epidemiccoronavirus disease 2019 global health crisiscoronavirus disease 2019 global pandemiccoronavirus disease 2019 health crisiscoronavirus disease 2019 pandemiccoronavirus disease 2019 public health crisiscoronavirus disease 2019 viruscoronavirus disease crisiscoronavirus disease epidemiccoronavirus disease pandemiccoronavirus disease-19coronavirus disease-19 global pandemiccoronavirus disease-19 pandemiccoronavirus disease-19 viruscoronavirus infectious disease-19cytokinedevelopmentalepidemic virusepigeneticallyexperimentexperimental researchexperimental studyexperimentsgene producthCoV19heavy metal Pbheavy metal leadhemorrhagic feverhost responseimmune system responseimmune system toleranceimmune unresponsivenessimmunological paralysisimmunoresponseimproved outcomeindividual responseindividualized responsekappa B Enhancer Binding ProteinmRNA Translationmedical countermeasurenCoV2network modelsnew drug treatmentsnew drugsnew pharmacological therapeuticnew therapeuticsnew therapynext generation therapeuticsnon-human primatenonhuman primatenovel drug treatmentsnovel drugsnovel pharmaco-therapeuticnovel pharmacological therapeuticnovel therapeuticsnovel therapynuclear factor kappa betaoutbreak containmentoutbreak controloutbreak mitigationposttranscriptionalprogramsproteogenomicsresponsesevere acute respiratory syndrome coronavirus 2 global health crisissevere acute respiratory syndrome coronavirus 2 global pandemicsocial rolethymus derived lymphocytetoll-like receptor 4tooltranscription factorubiquinationubiquitin conjugationvalidationsviral infectionvirus infectionvirus-induced disease
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

OVERALL: PROJECT SUMMARY/ABSTRACT
The central hypothesis of the proposed P01 Program is that Ebola virus infection leads to cell-type specific

transcriptional, posttranscriptional, and posttranslational alterations that create aberrant counterproductive

responses of immune cells, leading to a dysregulated immune response, which paradoxically produces “immune

paralysis” and hyperinflammation. To address the hypothesis, three Research Projects are proposed. Research

Project 1 focuses on pathogenic mechanisms at the transcriptional level, while Research Project 2 focuses on

posttranscriptional events, and Research Project 3 focuses on posttranslational modifications, each contributing

to the dysregulated immune response to Ebola virus. The dysregulated immune response is responsible for most

of the pathogenesis observed in Ebola virus disease.

All projects require the BSL-4 Core (Core B), which will be responsible for performing infections of human

immune and nonimmune cells, nonhuman primates, and the initial steps of experiments that involve infectious

virus. Importantly, Core B will provide each of the research projects samples from the same experimental

samples insuring that data from each project can be compared directly—this is a unique feature of this P01

Program. The Proteogenomics Core (Core C) will be responsible for massive parallel sequencing and mass

spectrometry-based studies. The Bioinformatics and Modeling Core (Core D) is critical for generating tools

employed in the experimental designs, including statistical help for OMICS experiments, analyzing OMICS data

and integrating OMICS data into networks that model the behavior of various cell populations infected with

EBOV. The work done in Core D will synthesize a model to explain how transcriptional, posttranscriptional, and

posttranslational responses of individual cell populations lead to immune dysregulation. The comprehensive

picture painted by this collaborative effort will revolutionize our understanding of the immunopathogenesis of

severe acute viral infections (e.g., immune imbalance seen in COVID-19). The Administrative Core (Core A)

will be responsible for strategic planning, continual evaluation, and communication and coordination of activities

among the various components of the project according to a detailed management plan.

The expected outcomes will contribute substantially to our knowledge of the fundamental mechanisms of the

immunopathogenesis of EBOV infections toward the development of effective countermeasures. The expected

outcomes will include (1) detailed knowledge of transcriptional mechanisms leading to the dysregulated immune

response to EBOV, (2) elucidation of the role of posttranscriptional mechanisms in the dysregulated immune

response to EBOV, (3) elucidation of the role of posttranslational mechanisms in the dysregulated immune

response to EBOV, and (4) experimental validation of the identified pathogenic mechanisms and their targeting.

The proposed tightly coordinated and comprehensive analysis has not been done before for any virus.

Grant Number: 5P01AI150585-05
NIH Institute/Center: NIH

Principal Investigator: Alexander Bukreyev

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →